These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6188103

  • 1. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J, Dhennin C, Guilbaud J.
    Nouv Rev Fr Hematol (1978); 1982; 24(6):375-81. PubMed ID: 6188103
    [Abstract] [Full Text] [Related]

  • 2. [Burns and heparin therapy: prekallikrein and other hemostatic parameters].
    Hainaut J, Guilbaud J, Carsin H.
    Agressologie; 1983 Nov; 24(11):539-40. PubMed ID: 6199993
    [No Abstract] [Full Text] [Related]

  • 3. [Aspects of hemostasis and the immunology of burns].
    Hainaut J.
    Biomed Pharmacother; 1987 Nov; 41(2):84-8. PubMed ID: 2440499
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
    Högström H, Claeson G, Larsson-Backström C, Lundberg D, Wenngren E, Haglund U.
    Acta Chir Scand; 1987 Mar; 153(3):161-4. PubMed ID: 3300117
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Dynamic changes in the hemostatic indices of diabetics during biostator control].
    Petkova M, Kamenov V, Tsanev A.
    Vutr Boles; 1989 Mar; 28(5):41-5. PubMed ID: 2482584
    [Abstract] [Full Text] [Related]

  • 10. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B, Tran TH, Ritz R, Duckert F.
    Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
    [Abstract] [Full Text] [Related]

  • 11. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P.
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract] [Full Text] [Related]

  • 12. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK, McRoyan CJ, Sauter KL, Liu PI, Daniel SJ.
    Ann Clin Lab Sci; 1985 Oct; 15(2):165-70. PubMed ID: 3158265
    [Abstract] [Full Text] [Related]

  • 13. Sepsis and antithrombin III, prekallikrein, and fibronectin levels in surgical patients.
    Wilson RF, Farag A, Mammen EF, Fujii Y.
    Am Surg; 1989 Jul; 55(7):450-6. PubMed ID: 2742228
    [Abstract] [Full Text] [Related]

  • 14. Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass.
    Wolk LA, Wilson RF, Burdick M, Selik N, Brown J, Starricco A, Mammen EF.
    Am Surg; 1985 Jun; 51(6):309-13. PubMed ID: 3873197
    [Abstract] [Full Text] [Related]

  • 15. Patients undergoing reconstructive surgery versus unburned children as "controls" in studies of pediatric patients with burns.
    Neely AN, Rieman MT, Warden GD.
    J Burn Care Rehabil; 1995 Jun; 16(4):418-21. PubMed ID: 8582921
    [Abstract] [Full Text] [Related]

  • 16. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 17. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T, Seki T, Miura R, Ogawara M, Yokouchi M, Yamanouchi H.
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract] [Full Text] [Related]

  • 18. Automated instrumentation and the laboratory diagnosis of bleeding and thrombotic disorders.
    Walenga J, Fareed J, Bermes EW.
    Semin Thromb Hemost; 1983 Jul; 9(3):172-93. PubMed ID: 6351253
    [No Abstract] [Full Text] [Related]

  • 19. Studies on pathological plasma proteolysis in patients with septicemia.
    Aasen AO, Smith-Erichsen N, Amundsen E.
    Scand J Clin Lab Invest Suppl; 1985 Jul; 178():37-45. PubMed ID: 3867120
    [Abstract] [Full Text] [Related]

  • 20. Homozygous type I plasminogen deficiency.
    Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V.
    Semin Thromb Hemost; 1997 Jul; 23(3):259-69. PubMed ID: 9255907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.